Hemodynamic efficacy of rapid saline infusion and dobutamine versus saline infusion alone in a model of cardiac rupture.
Despite recent reports describing survival after cardiac rupture, the effectiveness of circulatory support while awaiting definitive surgical treatment is controversial. To assess the efficacy of volume expansion and pharmacologic support in cardiac tamponade due to cardiac rupture, a model of hemorrhagic cardiac tamponade was developed and treatment with rapid saline infusion and dobutamine was compared with rapid saline infusion alone in 15 closed chest dogs. A right ventricular wound of reproducible size was produced by deflating an aortic valvuloplasty balloon that had previously been passed by way of the internal jugular vein into the pericardial space and through a stab wound in the right ventricular free wall. Hemodynamic values were compared at baseline, during tamponade and after a rapid infusion (1 liter at 100 ml/min) of either saline solution alone or saline solution plus dobutamine (20 micrograms/kg per min). Atrial and pericardial pressures increased significantly in both groups. Mean arterial pressure, cardiac output and stroke volume increased with combined saline and dobutamine infusion to values similar to those at baseline (91 +/- 19%, 114 +/- 43% and 94 +/- 37% of baseline, respectively). In contrast, saline infusion alone caused a small increase in cardiac output but failed to significantly increase mean arterial pressure or stroke volume (76.8 +/- 14.2%, 55 +/- 18% and 51 +/- 17% of baseline, respectively). Combined rapid infusion of saline solution and dobutamine infusion has a more beneficial hemodynamic effect and may be more effective than rapid saline infusion alone in resuscitating patients with hemorrhagic cardiac tamponade due to cardiac rupture.
Hoit
B D
BD
Division of Cardiology, University of Cincinnati Medical Center, Ohio 45267-0542.
Gabel
M
M
Fowler
N O
NO
D000818:Animals; D002305:Cardiac Tamponade / Q000209:etiology / Q000628:therapy*; D004280:Dobutamine / Q000627:therapeutic use*; D004285:Dogs; D006342:Heart Rupture, Post-Infarction / Q000150:complications / Q000628:therapy*; D006439:Hemodynamics / Q000502:physiology*; D010952:Plasma Substitutes / Q000008:administration & dosage*; D012965:Sodium Chloride / Q000008:administration & dosage*
D010952:Plasma Substitutes; D004280:Dobutamine; D012965:Sodium Chloride